[ad_1]
Europe’s medicines watchdog said Wednesday a preliminary probe showed that a batch of AstraZeneca vaccines used in Austria was likely not to blame for the death of a nurse who received a jab.
Austria on Monday announced it would stop using doses from the batch, made by the British-Swedish firm with Oxford University, after the 49-year-old nurse died of “severe blood coagulation problems” days after receiving an anti-COVID shot.
A second woman was also hospitalised after developing a pulmonary embolism and was now recovering, the European Medicines Agency said.
Two other reports of “thromboembolic event cases had been received for this batch,” the Amsterdam-based EMA said.
However “there is currently no indication that vaccination has caused these conditions, which are not listed as side effects with this vaccine,” it said in a statement.
Four other EU countries—Estonia, Latvia, Lithuania and Luxembourg—have also suspended vaccinations from this batch, sent to 17 European countries and consisting of one million jabs.
“Although a quality defect is considered unlikely at this stage, the batch quality is being investigated,” the EMA said.
Since inoculation campaigns began in earnest, isolated cases have been reported in some countries of people dying shortly after receiving a vaccine.
None has been linked to the vaccine.
Follow the latest news on the coronavirus (COVID-19) outbreak
© 2021 AFP
Citation:
AstraZeneca vaccine not to blame for Austria death: EMA (2021, March 10)
retrieved 10 March 2021
from https://medicalxpress.com/news/2021-03-astrazeneca-vaccine-blame-austria-death.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no
part may be reproduced without the written permission. The content is provided for information purposes only.
[ad_2]
Source link
- COVID case rates hit new high for England, study finds - April 7, 2022
- Govt’s focus on affordable healthcare ensured significant savings for poor, middle class: PM Modi - April 7, 2022
- SRL Diagnostics and Skye Air Mobility collaborate to transport pathology samples using drone logistics - April 6, 2022
- Healthineers sets up new production line of CT scanners in Bengaluru under PLI scheme - April 6, 2022
- Lupin inks licensing pact with Alvion to market drugs in Southeast Asia - April 6, 2022
- Yoga Mahotsav: Ayush Ministry to organise event to demonstrate common yoga on World Health Day - April 6, 2022
- LordsMed forays into the medtech space with launch of health ATMs ‘Lords Sehat’ - April 5, 2022
- ‘Friendly viruses’ can be the next big thing in the history of medical research and more - April 5, 2022
- No setback to Bharat Biotech even as WHO suspends Covaxin UN supply: Sources - April 4, 2022
- Govt panel recommends Serum’s Covovax dose for kids aged 12 and above - April 4, 2022
